Department of Chemistry, McGill University, Montreal, QC H3A 0B8, Canada.
Research School of Biology, The Australian National University, Acton, ACT 2601, Australia.
J Med Chem. 2021 Apr 22;64(8):4478-4497. doi: 10.1021/acs.jmedchem.0c01755. Epub 2021 Apr 1.
Malaria-causing parasites are developing resistance to antimalarial drugs, providing the impetus for new antiplasmodials. Although pantothenamides show potent antiplasmodial activity, hydrolysis by pantetheinases/vanins present in blood rapidly inactivates them. We herein report the facile synthesis and biological activity of a small library of pantothenamide analogues in which the labile amide group is replaced with a heteroaromatic ring. Several of these analogues display nanomolar antiplasmodial activity against and/or , and are stable in the presence of pantetheinase. Both a known triazole and a novel isoxazole derivative were further characterized and found to possess high selectivity indices, medium or high Caco-2 permeability, and medium or low microsomal clearance . Although they fail to suppress proliferation , the pharmacokinetic and contact time data presented provide a benchmark for the compound profile likely required to achieve antiplasmodial activity in mice and should facilitate lead optimization.
疟原虫寄生虫对抗疟药物产生耐药性,为新的抗疟药物提供了动力。虽然泛酰巯基乙胺显示出很强的抗疟原虫活性,但血液中的泛肽酶/万尼因会迅速将其水解,使其失活。本文报道了一种小的泛酰巯基乙胺类似物文库的简便合成和生物学活性,其中不稳定的酰胺基团被杂芳环取代。这些类似物中的几种对 和/或 具有纳摩尔级的抗疟原虫活性,并且在存在泛肽酶的情况下稳定。进一步对已知的三唑和新型异噁唑衍生物进行了表征,发现它们具有高选择性指数、中等到高的 Caco-2 通透性和中等到低的微粒体清除率。尽管它们不能抑制 增殖,但呈现的药代动力学和接触时间数据为在小鼠中实现抗疟原虫活性所需的化合物特征提供了基准,并且应该有助于先导化合物的优化。